AAP
TECH icon

Arax Advisory Partners’s Bio-Techne TECH Stock Holding History

Arax Advisory Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Sell
7,109
-4,434
-38% -$239K ﹤0.01% 1638
2026
Q1 		$603K Sell
11,543
-2,026
-15% -$122K 0.02% 579
2025
Q4 		$798K Sell
13,569
-10,664
-44% -$648K 0.02% 441
2025
Q3 		$1.35M Buy
24,233
+9,331
+63% +$500K 0.02% 560
2025
Q2 		$767K Sell
14,902
-424
-3% -$21.3K 0.04% 299
2025
Q1 		$899K Sell
15,326
-2,679
-15% -$182K 0.06% 199
2024
Q4 		$1.3M Buy
18,005
+43
+0.2% +$3.16K 0.08% 142
2024
Q3 		$1.44M Buy
17,962
+144
+0.8% +$10.8K 0.13% 92
2024
Q2 		$1.28M Buy
17,818
+2,374
+15% +$175K 0.12% 97
2024
Q1 		$1.09M Buy
15,444
+551
+4% +$39.4K 0.11% 98
2023
Q4 		$1.15M Buy
14,893
+786
+6% +$51.8K 0.13% 94
2023
Q3 		$960K Buy
14,107
+9,368
+198% +$740K 0.12% 99
2023
Q2 		$387K Buy
4,739
+617
+15% +$49.6K 0.05% 153
2023
Q1 		$306K Buy
4,122
+135
+3% +$10.4K 0.04% 180
2022
Q4 		$330K Buy
3,987
+55
+1% +$4.37K 0.05% 164
2022
Q3 		$279K Sell
3,932
-116
-3% -$10K 0.04% 163
2022
Q2 		$351K Buy
4,048
+232
+6% +$21.7K 0.05% 143
2022
Q1 		$413K Buy
3,816
+640
+20% +$66K 0.06% 131
2021
Q4 		$411K Hold
3,176
– – 0.05% 137
2021
Q3 		$385K Buy
3,176
+36
+1% +$4.38K 0.05% 124
2021
Q2 		$353K Buy
+3,140
New +$331K 0.05% 146
2020
Q4 		$309K Buy
3,892
+36
+0.9% +$2.61K 0.05% 136
2020
Q3 		$239K Buy
3,856
+232
+6% +$15.1K 0.04% 153
2020
Q2 		$239K Buy
3,624
+1,036
+40% +$62K 0.04% 151
2020
Q1 		$123K Sell
2,588
-72
-3% -$3.6K 0.03% 203
2019
Q4 		$146K Sell
2,660
-668
-20% -$35K 0.04% 200
2019
Q3 		$163K Buy
3,328
+568
+21% +$28.5K 0.05% 179
2019
Q2 		$144K Buy
+2,760
New +$139K 0.05% 184
2018
Q4 		$20K Hold
540
– – 0.01% 369
2018
Q3 		$28K Buy
+540
New +$23.9K 0.01% 363

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arax Advisory Partners's TECH Position: Q2 2026 in Review

Arax Advisory Partners reduced its Bio-Techne (TECH) stake by 38% in Q2 2026, selling an estimated $239K and leaving 7,109 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Arax Advisory Partners first reported a position in TECH in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.44M in Q3 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Arax Advisory Partners held 7,109 shares of Bio-Techne worth $502K as of Q2 2026.
  • Arax Advisory Partners sold 4,434 Bio-Techne shares in Q2 2026, an estimated $239K.
  • Bio-Techne made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1638 holding.
  • Arax Advisory Partners first reported a position in Bio-Techne in Q3 2018 and has held it in 30 quarters since.
  • Arax Advisory Partners's Bio-Techne position peaked at $1.44M in Q3 2024.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.